![IJMS | Free Full-Text | Modulatory Effects of Biosynthesized Gold Nanoparticles Conjugated with Curcumin and Paclitaxel on Tumorigenesis and Metastatic Pathways—In Vitro and In Vivo Studies IJMS | Free Full-Text | Modulatory Effects of Biosynthesized Gold Nanoparticles Conjugated with Curcumin and Paclitaxel on Tumorigenesis and Metastatic Pathways—In Vitro and In Vivo Studies](https://www.mdpi.com/ijms/ijms-23-02150/article_deploy/html/images/ijms-23-02150-g001.png)
IJMS | Free Full-Text | Modulatory Effects of Biosynthesized Gold Nanoparticles Conjugated with Curcumin and Paclitaxel on Tumorigenesis and Metastatic Pathways—In Vitro and In Vivo Studies
![Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial - The Lancet Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/c92530fa-bb64-433e-8c3b-9397a1b18008/gr2_lrg.jpg)
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial - The Lancet
![PDF) SPR064, a pro-drug of paclitaxel, has anti-tumorigenic effects in endometrial cancer cell lines and mouse models PDF) SPR064, a pro-drug of paclitaxel, has anti-tumorigenic effects in endometrial cancer cell lines and mouse models](https://i1.rgstatic.net/publication/344233037_SPR064_a_pro-drug_of_paclitaxel_has_anti-tumorigenic_effects_in_endometrial_cancer_cell_lines_and_mouse_models/links/60a3d422458515952dd8caad/largepreview.png)
PDF) SPR064, a pro-drug of paclitaxel, has anti-tumorigenic effects in endometrial cancer cell lines and mouse models
![PDF) Nab -paclitaxel Followed by Dose-dense Epirubicin/Cyclophosphamide in Neoadjuvant Chemotherapy for Triple-negative Breast Cancer: A Phase II Study PDF) Nab -paclitaxel Followed by Dose-dense Epirubicin/Cyclophosphamide in Neoadjuvant Chemotherapy for Triple-negative Breast Cancer: A Phase II Study](https://i1.rgstatic.net/publication/365759146_Nab_-paclitaxel_Followed_by_Dose-dense_EpirubicinCyclophosphamide_in_Neoadjuvant_Chemotherapy_for_Triple-negative_Breast_Cancer_A_Phase_II_Study/links/6381cd4248124c2bc6715172/largepreview.png)
PDF) Nab -paclitaxel Followed by Dose-dense Epirubicin/Cyclophosphamide in Neoadjuvant Chemotherapy for Triple-negative Breast Cancer: A Phase II Study
Phase I/II study of the combination of carboplatin and paclitaxel as first-line chemotherapy in patients with advanced epithelia
![Cancers | Free Full-Text | Everything Comes with a Price: The Toxicity Profile of DNA-Damage Response Targeting Agents Cancers | Free Full-Text | Everything Comes with a Price: The Toxicity Profile of DNA-Damage Response Targeting Agents](https://www.mdpi.com/cancers/cancers-14-00953/article_deploy/html/images/cancers-14-00953-g001.png)
Cancers | Free Full-Text | Everything Comes with a Price: The Toxicity Profile of DNA-Damage Response Targeting Agents
![In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies – topic of research paper in Biological sciences. Download scholarly article PDF and read In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies – topic of research paper in Biological sciences. Download scholarly article PDF and read](https://cyberleninka.org/viewer_images/1329479/f/1.png)
In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies – topic of research paper in Biological sciences. Download scholarly article PDF and read
![Tata Memorial Centre study claims carboplatin raises survival rate for breast cancer – The Raisina Hills Tata Memorial Centre study claims carboplatin raises survival rate for breast cancer – The Raisina Hills](https://theraisinahills.com/wp-content/uploads/2022/12/Breast-cancer.jpg)